Chugai Pharmaceutical Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Chugai Pharmaceutical stock has a consensus rating of "Buy" and an average price target of ¥10,097. The average 1-year stock price forecast is 27.94% higher than the current stock price, while the lowest is ¥8,200 (+3.90%) and the highest is ¥13,500 (+71.06%).

Price Target: ¥10,097 (+27.94%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	¥8,200	¥10,097	¥10,000	¥13,500
Change	+3.90%	+27.94%	+26.71%	+71.06%

Analyst Ratings

The average analyst rating for Chugai Pharmaceutical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26	May '26
Strong Buy	4	5	5	5	5	5
Buy	4	4	4	4	4	4
Hold	6	5	5	5	6	6
Sell	0	1	1	1	0	0
Strong Sell	0	0	0	0	0	0
Total	14	15	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Unknown Analyst Bank of America Securities No rating	Bank of America Securities	Hold Maintains ¥8,800	Hold	Maintains	¥8,800	+11.51%	May 26, 2026
Stephen Barker Jefferies	Jefferies	Hold Maintains ¥9,100 → ¥8,500	Hold	Maintains	¥9,100 → ¥8,500	+7.70%	May 12, 2026
Unknown Analyst Citi No rating	Citi	Buy Maintains ¥13,300 → ¥13,500	Buy	Maintains	¥13,300 → ¥13,500	+71.06%	Apr 30, 2026
Unknown Analyst Goldman Sachs No rating	Goldman Sachs	Hold Maintains ¥8,900 → ¥8,950	Hold	Maintains	¥8,900 → ¥8,950	+13.41%	Apr 27, 2026
Unknown Analyst Morgan Stanley No rating	Morgan Stanley	Buy Maintains ¥11,750 → ¥10,700	Buy	Maintains	¥11,750 → ¥10,700	+35.58%	Apr 27, 2026

More Analyst Ratings

Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. The data is sourced from Wall Street analysts. Data sources.